Clinical Laserthermia Systems AB (publ) carries out a directed issue of shares to set-off debt following a request for loan conversion by lenders
Lund, Sweden – Clinical Laserthermia Systems AB’s (“CLS” or the “Company”) has today, with the support of the authorization from the annual general meeting held on 28 June 2022, resolved on a directed share issue of 5,523,504 B-shares (the “Issue”) to Modelio Equity AB, Lubrica Equity AB and Formue Nord Fokus A/S (the “Lenders”) upon a request for conversion of debt totalling SEK 4.5 million, in accordance with the loan agreement that has been renegotiated and extended by CLS and the Lenders. The subscription price in the Issue is determined to SEK 0.8147 per new B-share, payment will be made